Goldman Sachs Group Inc Replimune Group, Inc. Transaction History

Goldman Sachs Group Inc

$596 Billion
Q1 2025

A detailed history of Goldman Sachs Group Inc transactions in Replimune Group, Inc. stock. As of the latest transaction made, Goldman Sachs Group Inc holds 690,167 shares of REPL stock, worth $6.73 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

690,167

Previous 690,167 -0.0%

Holding current value

$6.73 Million

Previous $6.73 Million -0.0%

% of portfolio

0.0%

Previous 0.0%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 09, 2025	BUY	$9.75 - $14.31 $1.16 Million - $1.7 Million	119,145 Added 20.87%	690,167 $6.73 Million
Q4 2024 Feb 11, 2025	SELL	$10.54 - $14.93 $511,084 - $723,955	-48,490 Reduced 7.83%	571,022 $6.92 Million
Q3 2024 Nov 14, 2024	SELL	$8.09 - $11.23 $376,710 - $522,924	-46,565 Reduced 6.99%	619,512 $6.79 Million
Q2 2024 Aug 13, 2024	BUY	$5.01 - $9.46 $765,212 - $1.44 Million	152,737 Added 29.75%	666,077 $5.99 Million
Q1 2024 May 15, 2024	SELL	$6.87 - $9.31 $11.9 Million - $16.1 Million	-1,725,543 Reduced 77.07%	513,340 $4.19 Million
Q4 2023 Feb 13, 2024	BUY	$6.75 - $16.18 $11.3 Million - $27.2 Million	1,679,553 Added 300.28%	2,238,883 $18.9 Million
Q3 2023 May 14, 2024	SELL	$15.96 - $22.18 $26.8 Million - $37.3 Million	-1,679,553 Reduced 75.02%	559,330 $9.57 Million
Q3 2023 Nov 14, 2023	SELL	$15.96 - $22.18 $852,950 - $1.19 Million	-53,443 Reduced 8.72%	559,330 $9.57 Million
Q2 2023 May 14, 2024	SELL	$15.65 - $24.1 $491,785 - $757,318	-31,424 Reduced 4.88%	612,773 $14.2 Million
Q2 2023 Aug 14, 2023	SELL	$15.65 - $24.1 $491,785 - $757,318	-31,424 Reduced 4.88%	612,773 $14.2 Million
Q1 2023 May 14, 2024	BUY	$17.48 - $29.09 $8.64 Million - $14.4 Million	494,009 Added 328.93%	644,197 $11.4 Million
Q1 2023 May 11, 2023	BUY	$17.48 - $29.09 $8.64 Million - $14.4 Million	494,009 Added 328.93%	644,197 $11.4 Million
Q4 2022 May 14, 2024	SELL	$17.09 - $27.91 $594,526 - $970,933	-34,788 Reduced 18.81%	150,188 $4.09 Million
Q4 2022 Feb 13, 2023	SELL	$17.09 - $27.91 $594,526 - $970,933	-34,788 Reduced 18.81%	150,188 $4.09 Million
Q3 2022 May 14, 2024	SELL	$15.6 - $21.15 $635,294 - $861,312	-40,724 Reduced 18.04%	184,976 $3.2 Million
Q3 2022 Nov 10, 2022	SELL	$15.6 - $21.15 $635,294 - $861,312	-40,724 Reduced 18.04%	184,976 $3.19 Million
Q2 2022 May 14, 2024	SELL	$13.32 - $19.98 $26.8 Million - $40.2 Million	-2,013,183 Reduced 89.92%	225,700 $3.95 Million
Q2 2022 Aug 15, 2022	BUY	$13.32 - $19.98 $1.12 Million - $1.68 Million	84,123 Added 59.42%	225,700 $3.95 Million
Q1 2022 May 16, 2022	BUY	$15.24 - $29.75 $553,608 - $1.08 Million	36,326 Added 34.51%	141,577 $2.4 Million
Q4 2021 Feb 14, 2022	SELL	$25.43 - $34.25 $3.45 Million - $4.65 Million	-135,699 Reduced 56.32%	105,251 $2.85 Million
Q3 2021 Nov 10, 2021	BUY	$28.98 - $39.54 $6.98 Million - $9.53 Million	240,950 New	240,950 $7.14 Million

Others Institutions Holding REPL

# of Institutions

172

Shares Held

78.5M

Call Options Held

69.4K

Put Options Held

216K

View Full List

About Replimune Group, Inc.

Ticker REPL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 49,306,700
Market Cap $481M
Description
Replimune Group, Inc., a biotechnology company, develops oncolytic immuno-gene therapies to treat cancer. It uses its proprietary Immunotherapy platform to design and develop product candidates that are intended to activate the immune system against cancer. The company's lead product candidate is RP1, a selectively replicating version of herpes ...

More about REPL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Goldman Sachs Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Goldman Sachs Group Inc with notifications on news.

Account

Goldman Sachs Group Inc Replimune Group, Inc. Transaction History